osteoporosis
OSTEOPOROSIS
Osteoporosis is a progressive, systemic skeletal disease characterized by decreased bone mass and micro-architectural deterioration of bone tissue leading to increased bone fragility and susceptibility to fractures.
The more risk factors (eg history of fracture, advanced age, comorbidities, etc) that are present, the greater the risk of fracture.

Osteoporosis Drug Information

Drug Information

Indication: Osteoporosis in postmenopausal women at increased risk of fracture. Increases bone mineral density & reduc...

Indication: Treatment & prevention of vit D deficiency. Adjunctive treatment for osteoporosis. Reduces risk of falling...

Indication: Osteoporosis in postmenopausal women & prevents fractures in men.

Indication: Testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clin...

Indication: Postmenopausal osteoporosis, to reduce the risk of fractures.

Cebion Vitamin C + Calcium Effervescent Tablet
ascorbic acid + calcium carbonate

Indication: Health supplement.

D-Cure
vitamin D

Indication: Prevention & treatment of vit D deficiency. Adjunctive therapy to osteoporosis in patients w/ vit D defici...

Indication: Osteoporosis in postmenopausal women & men at increased risk of fracture. Osteoporosis associated w/ susta...

Indication: Osteoporosis in postmenopausal women to increase bone mass, prevent fractures including those of the hip &...

1  /  6
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
05 Jun 2018
Men with systemic lupus erythematosus (SLE) are more likely to develop coronary artery calcifications (CAC) than age- and sex-matched controls, a recent study has shown. Such risk among patients with SLE is associated with older age, increasing chronic damage and cumulative dose of corticosteroids.